D
Dennis L. Andress
Researcher at University of Washington
Publications - 49
Citations - 5359
Dennis L. Andress is an academic researcher from University of Washington. The author has contributed to research in topics: Parathyroid hormone & Hyperparathyroidism. The author has an hindex of 31, co-authored 49 publications receiving 5079 citations. Previous affiliations of Dennis L. Andress include University of California, Los Angeles & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
Adeera Levin,George L. Bakris,Mark E. Molitch,Maartje Smulders,J. Tian,L. A. Williams,Dennis L. Andress +6 more
TL;DR: Multivariate analysis revealed that DM, increased urinary albumin/creatinine ratio and lower eGFR predicted lower values of 1,25 OH2 D3, but not 25(OH)D3 levels, were seen across deciles of eG FR (P<0.001).
Journal ArticleDOI
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Bryan Kestenbaum,Joshua N. Sampson,Kyle Rudser,Donald J. Patterson,Stephen L. Seliger,Bessie A. Young,Bessie A. Young,Donald J. Sherrard,Dennis L. Andress +8 more
TL;DR: Elevated serum phosphate levels were independently associated with increased mortality risk among this population of patients with chronic kidney disease and were associated with a significantly increased risk for death.
Journal ArticleDOI
Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.
TL;DR: It is suggested that a re-evaluation of current treatment recommendations is needed and that future research should focus on mechanisms that distinguish potential tissue specific benefits of selective VDR activators in patients with CKD.
Journal ArticleDOI
Survival following parathyroidectomy among United States dialysis patients.
Bryan Kestenbaum,Dennis L. Andress,Stephen M. Schwartz,Daniel L. Gillen,Stephen L. Seliger,Paresh R. Jadav,Donald J. Sherrard,Catherine Stehman-Breen +7 more
TL;DR: PTX was associated with higher short- term, and lower long-term, mortality rates among U.S. patients receiving chronic dialysis and measures to attenuate SHPTH may play an important role in reducing mortality among patients with end-stage renal disease.
Journal ArticleDOI
Antiepileptic Drug-Induced Bone Loss in Young Male Patients Who Have Seizures
Dennis L. Andress,Judy Ozuna,David L. Tirschwell,Lucinda A. Grande,Meshell D. Johnson,Arnold F. Jacobson,William J. Spain +6 more
TL;DR: Long-term AED therapy in young male patients who have seizures causes significant bone loss at the hip in the absence of vitamin D deficiency, and dual-energy x-ray absorptiometry scanning of the hip is useful in identifying patients who are particularly susceptible to rapid bone loss while taking AEDs.